Kallo Inc. Stock

Equities

KALO

US48343P2083

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 09:43:24 2023-12-18 am EST 5-day change 1st Jan Change
0.0003 USD -.--% Intraday chart for Kallo Inc. -.--% -.--%
Sales 2020 - Sales 2021 - Capitalization 97.89M
Net income 2020 -36M Net income 2021 -8M EV / Sales 2020 -
Net Debt 2020 1.36M Net Debt 2021 1.71M EV / Sales 2021 -
P/E ratio 2020
-1.21 x
P/E ratio 2021
-4.36 x
Employees 3
Yield 2020 *
-
Yield 2021
-
Free-Float 38.52%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0.0003
0.00
3 years
0.00
Extreme 0.0001
0.05
5 years
0.00
Extreme 0.0001
0.27
10 years
0.00
Extreme 0.0001
150.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 06-12-11
Chief Tech/Sci/R&D Officer - 14-11-30
Chief Operating Officer 76 11-09-21
Members of the board TitleAgeSince
Director/Board Member 89 09-12-30
Chief Executive Officer 62 06-12-11
Chief Operating Officer 76 11-09-21
More insiders
Kallo Inc. offers a healthcare delivery program. Its healthcare delivery program provides advanced healthcare solution that is customized to each country including infectious disease management and customized education and training programs. The Company’s technology suite transforms healthcare delivery through rural healthcare, disease management, clinical globalization, and e-health solutions. Its telehealth program is a technology connected to its global network of physicians, nurse practitioners, pharmacists, specialists, and surgeons specialized in minimal invasive procedures on a federated model. The telehealth program facilitates synchronous and asynchronous interactions where patients and staff are in different locations. Its maintenance services program includes three components: Biomedical Engineering services, Mechanical and Electrical Engineering services, and Information and Communications Technology.
More about the company